Sangamo Therapeutics on the New Frontiers of Genomic Medicine
Sangamo Therapeutics is working to translate groundbreaking science into genomic cures. Jason Fontenot, Senior Vice President and Chief Scientific Officer of Sangamo, discusses cutting-edge science on the frontiers of genomic medicine, and promising treatments for genomic diseases once thought to be intractable.
Frequently Asked Questions
What is the main topic discussed in this episode of Health Professional Radio?
This episode covers important developments in healthcare, including updates on Therapy. Health Professional Radio brings you expert insights and analysis on the latest medical news affecting healthcare professionals and patients alike.
How can healthcare professionals benefit from this information?
Healthcare professionals can stay informed about the latest developments in Therapy and related fields, enabling them to provide better patient care. Staying current with medical news helps clinicians make evidence-based decisions in their practice.
Where can I find more information about Therapy?
For more detailed information, listen to the full episode on Health Professional Radio and visit hpr.fm for additional resources. You can also subscribe to our podcast for regular updates on healthcare news and expert interviews.
Jason Fontenot, Ph.D., serves as Sangamo’s Chief Scientific Officer. He oversees all platform and pipeline research activities – advancing the company’s proprietary genomic medicine technology as well as proprietary and partnered pipeline programs. Dr. Fontenot has an extensive background in genome engineering, cell therapy and drug development, having previously served as Chief Scientific Officer at Immusoft, Head of Exploratory Research at Juno Therapeutics, and for nearly a decade as a group leader in the immunology department at Biogen. Dr. Fontenot has expertise in lymphocyte biology, cell and genetic engineering and immune-mediated disease. His seminal work on regulatory T cells and FOXP3 transformed the study of immune regulation and produced some of the most highly cited immunology publications of the last 20 years. Dr. Fontenot conducted post-doctoral work at Rockefeller University in New York City. He received his Ph.D. in Immunology from the University of Washington in Seattle.
Medical Disclaimer
The information provided on this website is for general informational purposes only and is not intended as medical advice. Always consult with a qualified healthcare professional for medical advice, diagnosis, or treatment. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.
